– USA, OH – Cleveland Diagnostics, Inc., a cancer biotechnology company, announced the appointment of Dara Grantham Wright to its Board as Independent Director.
About Dara Grantham Wright
Dara Grantham Wright is a growth-oriented leader with a demonstrated track record of building commercial success in the life sciences and clinical sectors with direct experience in both the Clinical Laboratory and In Vitro Diagnostics environments. She’s held successively senior executive leadership positions at several leading organizations, including Bio-Rad, Thermo Fisher Scientific, and Becton Dickinson.
“I am honored to join the Board of Directors at Cleveland Diagnostics,” said Dara Grantham Wright. “I look forward to supporting their mission of expanding access to leading-edge diagnostic tests to significantly enhance early cancer detection.”
About Cleveland Diagnostics, Inc.
Cleveland Diagnostics is a breakthrough cancer biotechnology company that is changing the shape of cancer detection. The company has unlocked the diagnostic power of protein structure with its revolutionary IsoClear platform that enables novel diagnostics based on a single cancer-specific, protein structure-based assessment using easy-to-execute tests within the clinical lab setting.
For more information : https://www.clevelanddx.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.